Literature DB >> 19565522

Analysis of Borrelia burgdorferi genotypes in patients with Lyme arthritis: High frequency of ribosomal RNA intergenic spacer type 1 strains in antibiotic-refractory arthritis.

Kathryn L Jones1, Gail A McHugh, Lisa J Glickstein, Allen C Steere.   

Abstract

OBJECTIVE: Most of the Borrelia burgdorferi genotypes have been isolated from erythema migrans (EM) skin lesions in patients with Lyme disease. OspC type K strains, which are 16S-23S ribosomal RNA intergenic spacer type 2 (RST2) strains, are most commonly recovered, but a higher percentage of OspC type A strains (RST1), the next most commonly recovered type, is detectable in blood. The goal of this study was to determine the B burgdorferi genotypes in the joints of patients with Lyme arthritis.
METHODS: Joint fluid samples from 124 patients seen over a 30-year period were analyzed for OspC types by semi-nested polymerase chain reaction (PCR) and sequencing, and for RSTs by nested PCR and restriction fragment length polymorphism analysis. These results were correlated with clinical outcome.
RESULTS: OspC and RST genotypes were identified in 49 of the 124 joint fluid samples (40%). In these 49 samples, OspC type K strains (RST2) were identified in 21 samples (43%), OspC type A strains (RST1) were identified in 11 samples (22%), and 8 other OspC types and all 3 RSTs were identified among the remaining 17 samples (35%). However, among the 17 patients who had been treated with antibiotics according to current guidelines, all 7 patients who were infected with RST1 strains had antibiotic-refractory arthritis, compared with 4 of 6 patients infected with RST2 strains and only 1 of 4 infected with RST3 strains (P = 0.03).
CONCLUSION: Most of the B burgdorferi genotypes, particularly OspC type K (RST2), were identified in the joint fluid of patients with Lyme arthritis, and the genotype frequencies found in joints reflected those in EM skin lesions. However, RST1 strains were most frequent in patients with antibiotic-refractory arthritis. Our results help to further the understanding of the differential pathogenicity of strains of B burgdorferi.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19565522      PMCID: PMC2753280          DOI: 10.1002/art.24812

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  42 in total

1.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

2.  Cultivation of Borrelia burgdorferi from joint fluid three months after treatment of facial palsy due to Lyme borreliosis.

Authors:  J Schmidli; T Hunziker; P Moesli; U B Schaad
Journal:  J Infect Dis       Date:  1988-10       Impact factor: 5.226

3.  Molecular characterization of the OspA(161-175) T cell epitope associated with treatment-resistant Lyme arthritis: differences among the three pathogenic species of Borrelia burgdorferi sensu lato.

Authors:  Elise E Drouin; Lisa J Glickstein; Allen C Steere
Journal:  J Autoimmun       Date:  2004-11       Impact factor: 7.094

4.  Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis.

Authors:  J J Nocton; F Dressler; B J Rutledge; P N Rys; D H Persing; A C Steere
Journal:  N Engl J Med       Date:  1994-01-27       Impact factor: 91.245

5.  Borrelia burgdorferi in joint fluid in chronic Lyme arthritis.

Authors:  D R Snydman; D P Schenkein; V P Berardi; C C Lastavica; K M Pariser
Journal:  Ann Intern Med       Date:  1986-06       Impact factor: 25.391

6.  The clinical evolution of Lyme arthritis.

Authors:  A C Steere; R T Schoen; E Taylor
Journal:  Ann Intern Med       Date:  1987-11       Impact factor: 25.391

7.  Genetic diversity among Borrelia strains determined by single-strand conformation polymorphism analysis of the ospC gene and its association with invasiveness.

Authors:  Vanessa Lagal; Danièle Postic; Eva Ruzic-Sabljic; Guy Baranton
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

8.  Sequence typing reveals extensive strain diversity of the Lyme borreliosis agents Borrelia burgdorferi in North America and Borrelia afzelii in Europe.

Authors:  Jonas Bunikis; Ulf Garpmo; Jean Tsao; Johan Berglund; Durland Fish; Alan G Barbour
Journal:  Microbiology       Date:  2004-06       Impact factor: 2.777

9.  Treatment of late Lyme borreliosis--randomised comparison of ceftriaxone and penicillin.

Authors:  R J Dattwyler; J J Halperin; D J Volkman; B J Luft
Journal:  Lancet       Date:  1988-05-28       Impact factor: 79.321

10.  Successful parenteral penicillin therapy of established Lyme arthritis.

Authors:  A C Steere; J Green; R T Schoen; E Taylor; G J Hutchinson; D W Rahn; S E Malawista
Journal:  N Engl J Med       Date:  1985-04-04       Impact factor: 91.245

View more
  29 in total

1.  Treg cell numbers and function in patients with antibiotic-refractory or antibiotic-responsive Lyme arthritis.

Authors:  Shiqian Shen; Junghee J Shin; Klemen Strle; Gail McHugh; Xin Li; Lisa J Glickstein; Elise E Drouin; Allen C Steere
Journal:  Arthritis Rheum       Date:  2010-07

Review 2.  Diagnosis and treatment of Lyme arthritis.

Authors:  Sheila L Arvikar; Allen C Steere
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

3.  Matrix metalloproteinase-10 is a target of T and B cell responses that correlate with synovial pathology in patients with antibiotic-refractory Lyme arthritis.

Authors:  Jameson T Crowley; Klemen Strle; Elise E Drouin; Annalisa Pianta; Sheila L Arvikar; Qi Wang; Catherine E Costello; Allen C Steere
Journal:  J Autoimmun       Date:  2016-02-26       Impact factor: 7.094

Review 4.  Evolutionary aspects of emerging Lyme disease in Canada.

Authors:  N H Ogden; E J Feil; P A Leighton; L R Lindsay; G Margos; S Mechai; P Michel; T J Moriarty
Journal:  Appl Environ Microbiol       Date:  2015-08-21       Impact factor: 4.792

Review 5.  Lyme borreliosis.

Authors:  Allen C Steere; Franc Strle; Gary P Wormser; Linden T Hu; John A Branda; Joppe W R Hovius; Xin Li; Paul S Mead
Journal:  Nat Rev Dis Primers       Date:  2016-12-15       Impact factor: 52.329

6.  Association of a Toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritis.

Authors:  Klemen Strle; Junghee J Shin; Lisa J Glickstein; Allen C Steere
Journal:  Arthritis Rheum       Date:  2012-05

Review 7.  Challenges in the Diagnosis and Treatment of Lyme Disease.

Authors:  Robert T Schoen
Journal:  Curr Rheumatol Rep       Date:  2020-01-07       Impact factor: 4.592

8.  Borrelia burgdorferi RST1 (OspC type A) genotype is associated with greater inflammation and more severe Lyme disease.

Authors:  Klemen Strle; Kathryn L Jones; Elise E Drouin; Xin Li; Allen C Steere
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

Review 9.  Review: unraveling Lyme disease.

Authors:  Linda K Bockenstedt; Gary P Wormser
Journal:  Arthritis Rheumatol       Date:  2014-09       Impact factor: 10.995

10.  A novel human autoantigen, endothelial cell growth factor, is a target of T and B cell responses in patients with Lyme disease.

Authors:  Elise E Drouin; Robert J Seward; Klemen Strle; Gail McHugh; Kianoosh Katchar; Diana Londoño; Chunxiang Yao; Catherine E Costello; Allen C Steere
Journal:  Arthritis Rheum       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.